BGLC
BioNexus Gene Lab Corp.
NASDAQ · Healthcare · Medical - Diagnostics & Research · MY
$1.57
+6.44%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.59x
- Price / sales
- 1.47x
- Price / cash flow
- -5.47x
Enterprise value
- Enterprise value
- $1.3M
- EV / sales
- 0.41x
- EV / EBITDA
- -0.53x
- EV / EBIT
- -0.50x
- Market cap
- $4.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026